Ascent Industries (CSE:ASNT) COO Reid Parr was interviewed by Proactive Investors. He provided a status update for the Agrima Labs, Botanicals and Meadows campuses in British Columbia. The Agrima Botanicals facility is currently operating at full capacity and is harvesting crops on a weekly basis, while their Meadows and Lab facilities are currently under review with Health Canada and will be completing phase one construction by the end of 2018. Agrima Labs will be their e-commerce and global distribution centre as they have their dealer’s license which allows them to distribute cannabis throughout Canada and the world.

Parr also provided an update on the status on the company’s holdings in Nevada and Oregon. They have been licensed as producer-processors and distributors in Oregon and Nevada. They are also currently selling over 40 of their products in 130 dispensaries in both states. Additionally, Parr discussed the company’s expansion plans into Denmark. Denmark provides a highly respected healthcare industry, but allows more cannabis derived products than Germany currently does.

“We’re very excited to be expanding into Europe,” said Parr. “We’ve secured a Level 10 GMP pharmaceutical distribution facility. We’re in the application phase for a controlled drug license, a dealers license and medical cannabis pilot program license.”

Ascent has defined itself in part as a research company. They’ve been conducting research for the past five years in house and with Simon Fraser University. The company focuses on five areas of research: genetics, product development, preclinical research, production and manufacturing optimization and market research.

To view the interview, click here.

Click here to connect with Ascent Industries (CSE:ASNT) for an Investor Presentation.



The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less